TCG CROSSOVER MANAGEMENT, LLC Aclaris Therapeutics, Inc. Transaction History

TCG CROSSOVER MANAGEMENT, LLC portfolio value:

$18.02M
portfolio value

TCG CROSSOVER MANAGEMENT, LLC quarter portfolio value change:

+12.75%
quarter

Aclaris Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 2.03M $15.74 1.14M
Q2 2022 share 0.00% 0 shares -3.75M $13.96 1.14M
Q1 2022 share Increase +5.80% 62.72K shares 4.00M $17.24 1.14M
Q4 2021 share Increase 0.00% 1.08M shares 15.73M $14.33 1.08M